Roberto Sorio

6.4k citations
141 papers · 4.8k · 2 hit papers · h-index 29

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 5%
    • PARP inhibition in cancer therapy
    • Cancer Treatment and Pharmacology

Papers in

    • Ovarian cancer diagnosis and treatment 56
    • Cancer Treatment and Pharmacology 13
    • PARP inhibition in cancer therapy 6

Roberto Sorio

132 papers receiving 4.6k citations

Roberto Sorio's Hit Papers

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial 2014 · 1.3k citations
1.3k0+4+8Years since publication4008001.2k

Peers

Roberto Sorio
Comparison fields: 5 of 95
  • Reproductive Medicine 2k
  • Oncology 889
  • Geriatrics and Gerontology 102
  • Cancer Research 386
  • Obstetrics and Gynecology 132
Replace Philippe Follana with:
Philippe Follana France
Jean‐Paul Guastalla France
Gennaro Daniele Italy
Jermaine I Coward Australia
Laurence Gladieff France
Stephen A. Welch Canada
Frédèric Selle France
Jing Yi United States
Robert J. Morgan United States
Koji Matsumoto Japan
Roberto Sorio relative to Philippe Follana France Philippe Follana's profile →
Citations per field
00.5×2×3×4.4×
Philippe Follana · 1×
Citations per year

Countries citing papers authored by Roberto Sorio

Since Specialization
Citations

This map shows the geographic impact of Roberto Sorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Sorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Sorio more than expected).

Fields of papers citing papers by Roberto Sorio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Sorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Sorio. The network helps show where Roberto Sorio may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Sorio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Sorio Line = papers co-authored together Roberto Sorio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Hit paper breakdown →
20141301
2
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Hit paper breakdown →
2014299
3 2013169
4 2011167
5 1996151
6 1998150
7 2014143
8 2016103
9 2007101
10 199578
11 199578
12 201770
13 201769
14 201969
15 199762
16 199659
17 199651
18 200151
19 200749
20 201549

About Roberto Sorio

Roberto Sorio is a scholar working on Reproductive Medicine, Oncology, Pharmacology, Cancer Research and Toxicology, having authored 141 papers that have together received 4.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (56 papers), Cancer therapeutics and mechanisms (14 papers), Cancer Treatment and Pharmacology (13 papers), Pharmacogenetics and Drug Metabolism (8 papers), Lymphoma Diagnosis and Treatment (7 papers), PARP inhibition in cancer therapy (6 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Reproductive Medicine (2k citations), Oncology (889 citations), Geriatrics and Gerontology (102 citations), Cancer Research (386 citations) and Obstetrics and Gynecology (132 citations). Roberto Sorio has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Éric Pujade-Lauraine, Felix Hilpert, Mansoor Raza Mirza, Silvio Monfardini, Ignace B. Vergote, Petronella Oda Witteveen, Pauline Wimberger, Gunnar Balle Kristensen, Philippe Follana and Alexander Reuß. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Oncology, Cancer Chemotherapy and Pharmacology and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact